PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
93 hedge funds and large institutions have $92.2M invested in Paratek Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
15% less call options, than puts
Call options by funds: $350K | Put options by funds: $414K
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
93
Holding in Top 10
3
Calls
$350K
Puts
$414K
Top Buyers
| 1 | +$4.99M | |
| 2 | +$2.8M | |
| 3 | +$2.15M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$1.81M |
| 5 |
D.E. Shaw & Co
New York
|
+$975K |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$1.67M | |
| 3 | -$1.3M | |
| 4 |
RA
Royce & Associates
New York
|
-$1.27M |
| 5 |
APCM
Arbiter Partners Capital Management
New York
|
-$1.04M |